US speciality firms ripe for acquisition, says McKinsey
This article was originally published in Scrip
Executive Summary
Pharmaceutical companies should spend on the right opportunities during the recession, and one such ripe opportunity for Indian companies is to acquire US speciality firms, according to the management consultancy McKinsey & Co.